A Phase 3 randomized, controlled trial of myocet, trastuzumab and paclitaxel vs. trastuzumab and paclitaxel for 1st line therapy of HER2+ metastatic breast cancer Meeting Abstract

  

Authors:	Baselga, J.; Manikhas, A.; Roman, L.; Semiglazov, V.; Goldfarb, R. H.; Forenza, S.; Matera, J.; Azarnia, N.; Hudis, C.; Rozencweig, M.
Abstract Title:	A Phase 3 randomized, controlled trial of myocet, trastuzumab and paclitaxel vs. trastuzumab and paclitaxel for 1st line therapy of HER2+ metastatic breast cancer
Meeting Title:	33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS)
Journal Title:	Cancer Research
Volume:	70
Issue:	24 Suppl.
Meeting Dates:	2010 Dec 9-12
Meeting Location:	San Antonio, TX
ISSN:	0008-5472
Publisher:	American Association for Cancer Research
Date Published:	2010-12-15
Language:	English
ACCESSION:	WOS:000209695800308
DOI:	10.1158/0008-5472.sabcs10-p6-14-02
PROVIDER:	wos
Notes:	Meeting Abstract: P6-14-02 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/99192